Age-related hearing loss cure and prevention: An expert shares the details about presbycusis treatment and tips on reversing hearing loss ...

Struggling with the constant buzz of tinnitus or the frustration of hearing loss? You’re not alone and you’re not without hope. More than 50 million Americans live with tinnitus, and millions more ...

Geriatrics and Aging. 2005;8(6):46-49. Hearing loss that occurs instantaneously or over a period of a few days without immediately apparent cause is called Idiopathic Sudden Sensorineural Hearing Loss ...

Hearing aids are often the first step for treating mild to moderate hearing loss, amplifying sounds the ear can still detect. When hearing aids aren’t sufficient, various implantable devices like ...

BOCA RATON, Fla. — Dr. Adrien Eshraghi, a surgeon-scientist, specializes in hearing disorders and focuses his research on helping patients like Kelsie Gonzalez. Eshraghi is a University of Miami ...

The three types of hearing loss are sensorineural, conductive, and mixed hearing loss. They each involve different parts of the ear and may have varying causes and treatments. Hearing loss in one or ...

To date, more than 50% of the patients in the study have been enrolled in seven European countries. The study is testing AC102 as a novel, more effective treatment for sudden hearing loss with fewer ...

Researchers have understood for decades that some forms of deafness are inherited, yet until now, few of those genetic clues have led the way to therapy. That is beginning to change. An international ...

A woman having trouble with hearing gestures for increased volume. [Getty Images] Hearing loss is one of the world's most prevalent chronic conditions, affecting people of all ages. It interferes with ...

Intra-arterial Paraplatin did not cause hearing loss in children with retinoblastoma, as shown by DPOAE testing. DPOAE testing is a noninvasive, reliable method for assessing cochlear function and ...

BERLIN--(BUSINESS WIRE)--Berlin-based start-up AudioCure Pharma has enrolled more than 50% of the planned patients in its ongoing Phase 2 clinical trial. The aim of the study is to test the efficacy ...